1. Metabolic Enzyme/Protease Vitamin D Related/Nuclear Receptor
  2. ROR
  3. RORγt inverse agonist 29

RORγt inverse agonist 29 是一种有效的、具有口服活性的 RORγt 选择性反向激动剂 (IC50: 21 nM)。RORγt inverse agonist 29 可用于皮肤炎症和银屑病等自身免疫性疾病的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

RORγt inverse agonist 29 Chemical Structure

RORγt inverse agonist 29 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

查看 ROR 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

RORγt inverse agonist 29 is a potent, orally active and selective RORγt inverse agonist (IC50: 21 nM). RORγt inverse agonist 29 can be used in the research of skin inflammation and autoimmune diseases like psoriasis[1].

IC50 & Target[1]

RORγt

21 nM (IC50)

体外研究
(In Vitro)

RORγt inverse agonist 29 (compound b12) demonstrates high RORγt transcriptional inhibitory activity (IC50: 28 nM) in human Jurkat cells[1].
RORγt inverse agonist 29 (10 μM) shows good metabolic stabilities in in vitro human liver microsomes, with comparable half-life (T1/2: 4.46 h) and HLM (CLint(liver): 4.8 mL/min/kg)[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

RORγt inverse agonist 29 (p.o., 100 mg/kg) reduces the total Psoriasis Area and the development of clinical symptoms in mouse Imiquimod-induced skin inflammation model[1].
RORγt inverse agonist 29 (i.v., p.o., 0.3 or 1 mg/kg) displays an acceptable bioavailability and a half-life in rats[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Mouse Imiquimod-induced skin inflammation model[1]
Dosage: 15 mg/kg, 50 mg/kg, 100 mg/kg
Administration: Oral administration, twice a day for 13 days.
Result: Inhibited IL-6 and IL-17A protein in the serum, with inhibition rate of 58.06% (IL-6) and 84.07% (IL-17A) at 100 mg/kg.
Reduced the histopathological symptoms on the back skin at dose of 100 mg/kg.
Alleviated symptoms including mononuclear and inflammatory cell infiltration, skin layer thickening, and dermal telangiectasia.
Animal Model: Rats (pharmacokinetic assay)[1]
Dosage: 0.3 mg/kg (i.v.), 1 mg/kg (p.o.)
Administration: Intravenous injection, oral administration
Result: Pharmacokinetic profile of RORγt inverse agonist 29 (compound b12).
administration route T1/2 (h) Tmax (h) Cmax (ng/mL) AUC0-t (ng•h/mL) AUC0-∞ (ng•h/mL) F (%)
i.v. (0.3 mg/kg) 5.8 2.4 88 156 162
p.o. (1 mg/kg) 6.5 3.1 105 340 352 65
分子量

464.53

Formula

C25H24N2O5S

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
RORγt inverse agonist 29
目录号:
HY-143271
需求量: